Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Kappa selective opioid receptor antagonist

Kappa selective opioid receptor antagonist

US Patent 7709522 · Granted May 4, 2010

Estimated economic value: $107,193,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

6-methoxy-3,4-dihydro-1H-isoquinolin compounds2025
Pyrrolidine compounds2025
Pyrrolidine compounds2022
4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonist2015
4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mGluR 2/32014
Opioid receptor antagonists2012
Spiropiperidine compounds as ORL-1 receptor antagonists2012
Kappa selective opioid receptor antagonist2012
Kappa selective opioid receptor antagonist2012
Kappa selective opioid receptor antagonist2012
Methods of treatment using a prodrug of an excitatory amino acid2011
Opioid receptor antagonists2011